Webinar: Safe and Effective Use of Medications in Older Adults

April 4, 2018

Register for April 18 webinar.

Beneficiaries dually eligible for Medicare and Medicaid have on average, a 25 percent higher rate of chronic conditions than beneficiaries who are not dually eligible. Dually eligible beneficiaries also tend to use a variety of medications and have higher Medicare Part D prescription drug costs than Medicare-only beneficiaries. Addressing medication management, medication misuse, and adverse drug effects among dually eligible beneficiaries is important for the health of these individuals.

Please join Resources for Integrated Care for a webinar on April 18 at 12:00 PM Eastern. The speakers will provide an overview of these important  medication issues related to older adults, along with the need for management and coordination among the care team members and the beneficiary. Participants will also learn about effective strategies to empower individuals and their families to manage multiple medications for maintaining their health.

Participants in the webinar will be able to: 

  • Define polypharmacy and the implications for patient safety;
  • Name at least five classes of medications that are known to have a high risk of adverse reactions in older adults; and
  • Recognize challenges that beneficiaries and their family members may experience when managing multiple medications, and define how each member of the care team can assist with medication regimens.

Register for the webinar.

By clicking “save,” I acknowledge that all fields marked with an asterisk are required. We ask for your email address so we can contact you for additional information if necessary. Your email address will not be published on the public site. Your name and your comment may remain published on this site indefinitely. We will delete any comments that include vulgar language, hate speech or personal attacks, or which do not pertain to the topic at hand. We also may delete comments that include personal information about another person. If a comment is received that contains non-publishable material, we reserve the right to either edit the comment to remove these elements or to delete the comment.

Last modified on 04/04/2018

Back to Top